focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 9.60
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trial

Mon, 31st Jul 2023 10:46

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Scancell Holdings PLC, up 25% at 11.52 pence, 12-month range 8.65p-29.40p. The cancer immunotherapies developer says it has expanded its Modi-1 trial for the use of checkpoint inhibitors on cancer patients. Scancell says the safety review committee has approved the addition of two new cohorts of 21 patients each. This move follows the successful completion of cohort four of the trial, which showed that patients with renal, head and neck cancer who received at least two doses of Modi-1 combined with CPI tolerated the treatment well, with no safety concerns.

----------

Tertiary Minerals PLC, up 12% at 0.10p, 12-month range 0.083p-0.31p. The mineral exploration and development company says it has received permission from the Forest Department of Zambia to carry out soil sampling in forested areas at its Mukai and Mushima North project licenses. The firm says it is exploring the two license areas for copper, with two targets, C1 and A1, identified at Mushima. Chair Patrick Cheetham says: "Our objective is to now complete soil sampling over the exciting targets we have developed at Mushima North and Mukai as well as at our Konkola West Project. This will enable us to prioritise our Zambian Projects for follow up drilling having already completed similar programmes at our Lubuila and Jacks Projects."

----------

AIM - LOSERS

----------

Aptamer Group PLC, down 45% at 2.64p, 12-month range 2.00p-100.00p. The provider of Optimer binders for use in therapeutics, diagnostics, bioprocessing and research says it has terminated its sale process after announcing it had conditionally completed a fundraise. The company says it conditionally raised GBP3.6 million, and accordingly the board decided to terminate the formal sale process. "The company is not in discussions with any party in relation to a sale and is not in receipt of any approaches," says Aptamer. The company also reveals that Chair Ian Gilham and Interim Chief Executive Officer & Chief Financial Officer Rob Quinn have resigned, effective from August 21. The company announced that it had appointed Steve Hull as chair from the same date, and promoted Andrew Rapson, current head of finance, to CFO.

----------

Jadestone Energy PLC, down 32% at 23.70p, 12-month range 23.00p-103.00p. The oil and gas production company focused on the Asia-Pacific region says production is temporarily shut at Montara floating production storage and offloading facility offshore Australia due to a gas alarm in tank 4S. It says the tank will be emptied, cleaned and inspected over the next few weeks. Production at Montara had only resumed in March after closing down in August of last year for repair activities. Chief Executive Officer Paul Blakeley says: "While disappointing and frustrating to have to shut in Montara again, we will find and repair any additional defect while continuing with the overall planned programme of inspection of the storage tanks on the FPSO. The safety of our personnel, as well as the long-term integrity of the asset, are paramount. We will provide a further update once the inspection of tank 4S is complete."

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
22 Jul 2020 11:24

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue

Read more
24 Jun 2020 12:18

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Scancell To Start Clinical Trial For Cancer Treatment In 2021

Read more
12 Jun 2020 12:59

Scancell upbeat on publication of AvidiMab research

(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.

Read more
28 Apr 2020 16:40

Director dealings: Scancell director lowers stake

(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.

Read more
28 Apr 2020 14:43

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

Read more
24 Apr 2020 12:00

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Scancell Rises On Launch Of Covid-19 Vaccine Research Programme

Read more
24 Apr 2020 10:49

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost

Read more
3 Feb 2020 14:20

Scancell's 'SCIB1' clears latest regulatory hurdle in US

(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.

Read more
3 Feb 2020 10:44

Scancell Gets US FDA Approval For SCIB1 Drug Application

Scancell Gets US FDA Approval For SCIB1 Drug Application

Read more
31 Jan 2020 11:12

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Scancell Interim Loss Narrows, Progresses On Product Pipeline

Read more
20 Jan 2020 12:04

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment

Read more
18 Dec 2019 16:29

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 3 Million Shares

Read more
16 Dec 2019 13:30

Scancell inks AvidiMab agreement with Chinese biotech company

(Sharecast News) - Scancell Holdings on Monday signed a collaboration and non-exclusive research agreement with an unnamed Chinese biotechnology firm.

Read more
16 Dec 2019 09:21

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Scancell Shares Jump As It Secures First Deal In China For AvidiMab

Read more
12 Dec 2019 14:23

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Oxford Technology VCTs Report Mixed Third-Quarter Performances

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.